147 related articles for article (PubMed ID: 20184937)
1. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
[No Abstract] [Full Text] [Related]
2. Treatment of valproate-induced hyperammonemia.
Stewart JT
J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
[No Abstract] [Full Text] [Related]
3. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
4. [Hyperammoniemia and central pontine myelinolysis in a patient with Sjögren syndrome and chronic valproate use].
Berlot G; Battaglia K; Ukmar M
Recenti Prog Med; 2008 Oct; 99(10):502-4. PubMed ID: 19040128
[TBL] [Abstract][Full Text] [Related]
5. Clinical alertness to valproic acid-induced hyperammonemia--two case reports.
Shan JC; Hsieh MH; Liu CC; Wen CC; Liu CM
J Psychopharmacol; 2010 Jun; 24(6):943-5. PubMed ID: 19304858
[No Abstract] [Full Text] [Related]
6. Valproate-related hyperammonemic encephalopathy: report of 1 case.
Selvi Y; Annagur BB; Sayin AA; Akbaba N
J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
[No Abstract] [Full Text] [Related]
7. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
8. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
Dealberto MJ
Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
[TBL] [Abstract][Full Text] [Related]
9. A case of valproate-induced encephalopathy.
Hong L; Schutz J; Nance M
Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
[No Abstract] [Full Text] [Related]
10. Valproate-induced hyperammonaemia.
Raja M; Azzoni A
J Clin Psychopharmacol; 2002 Dec; 22(6):631-3. PubMed ID: 12454569
[No Abstract] [Full Text] [Related]
11. Risperidone, a risk factor for valproate-induced encephalopathy?
Rodrigues-Silva N; Venâncio Â; Bouça J
Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia associated with valproic acid use in elderly psychiatric patients.
Holroyd S; Overdyke JT
J Neuropsychiatry Clin Neurosci; 2012; 24(3):372-4. PubMed ID: 23037652
[TBL] [Abstract][Full Text] [Related]
13. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
14. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
Elgudin L; Hall Y; Schubert D
Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS
Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
[No Abstract] [Full Text] [Related]
16. Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting.
Dealberto MJ; Sarazin FF
J Neuropsychiatry Clin Neurosci; 2008; 20(3):369-71. PubMed ID: 18806245
[No Abstract] [Full Text] [Related]
17. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
Dawson LP; Lee SJ; Hollander YS
Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
[No Abstract] [Full Text] [Related]
18. Hyperammonemia induced by interaction of valproate and quetiapine.
Halaby A; Haddad R; Naja WJ
Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
[TBL] [Abstract][Full Text] [Related]
19. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
Lewis C; Tesar GE; Dale R
Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
[TBL] [Abstract][Full Text] [Related]
20. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.
Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M
Medicine (Baltimore); 2017 Sep; 96(39):e8117. PubMed ID: 28953637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
